Literature DB >> 19761767

Cell adaptation to activated FGFR3 includes Sprouty4 up regulation to inhibit the receptor-mediated ERKs activation from the endoplasmic reticulum.

Patricia M-J Lievens1, Elena Zanolli, Silvio Garofalo, Elio Liboi.   

Abstract

The kinase activity of the thanatophoric dysplasia type II-fibroblast growth factor receptor 3 mutant (TDII-FGFR3) hampers its maturation. As a consequence, the immature receptor activates extracellular regulated kinases (ERKs) from the endoplasmic reticulum (ER), which leads to apoptosis. On the other hand, in stable TDII-FGFR3 cells receptor biosynthesis is restored and ERKs are activated from the cell surface. To identify potential mediators of cell adaptation to the activated receptor we investigated gene products that are differently regulated in TDII and wild-type FGFR3 cells. cDNA representational difference analysis reveals Sprouty4 up regulation in the TDII-FGFR3 cells. Interestingly, Sprouty4 inhibits the TDII-FGFR3-mediated ERKs activation from the ER, but fails to suppress ERKs activation from cell surface. We conclude that cell adaptation to activated FGFR3 include Sprouty4 activity, which silences the premature receptor signaling and suppress apoptosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19761767     DOI: 10.1016/j.febslet.2009.09.021

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  2 in total

1.  Insights into the Proteome of Gastrointestinal Stromal Tumors-Derived Exosomes Reveals New Potential Diagnostic Biomarkers.

Authors:  Safinur Atay; Daniel W Wilkey; Mohammed Milhem; Michael Merchant; Andrew K Godwin
Journal:  Mol Cell Proteomics       Date:  2017-12-14       Impact factor: 5.911

2.  Expression of FGFR3 Protein and Gene Amplification in Urinary Bladder Lesions in Relation to Schistosomiasis.

Authors:  Olfat Hammam; Tarek Aboushousha; Ali El-Hindawi; Hosni Khairy; Heba Khalil; Amira Kamel; Maha Akl; Ahmed Abdel-Hady; Mona Magdy; Mohamed Badawy; Amr El Kholy; Khalid Al Osili; Nora Kamel; Shady Anis; Tarek El Leithy
Journal:  Open Access Maced J Med Sci       Date:  2017-04-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.